Fei Mao

8.4k total citations · 4 hit papers
136 papers, 6.4k citations indexed

About

Fei Mao is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Fei Mao has authored 136 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 47 papers in Cancer Research and 38 papers in Immunology. Recurrent topics in Fei Mao's work include Extracellular vesicles in disease (32 papers), Mesenchymal stem cell research (30 papers) and MicroRNA in disease regulation (29 papers). Fei Mao is often cited by papers focused on Extracellular vesicles in disease (32 papers), Mesenchymal stem cell research (30 papers) and MicroRNA in disease regulation (29 papers). Fei Mao collaborates with scholars based in China, Ghana and United States. Fei Mao's co-authors include Hui Qian, Wenrong Xu, Yongmin Yan, Xu Zhang, Dickson Kofi Wiredu Ocansey, Wei Zhu, Bin Zhang, Hui Shi, Mei Wang and Cheng Ji and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Fei Mao

133 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro

2013 516 citations Wenrong Xu, Bin Zhang et al. profile →
Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction

2018 354 citations Yaoxiang Sun, Hui Shi et al. ACS Nano profile →
Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy

2022 209 citations Cheng Ji, Hui Shi et al. profile →
The emerging role of oxidative stress in inflammatory bowel disease

2024 79 citations Fei Mao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fei Mao China	44	4.1k	2.3k	1.4k	944	940	136	6.4k
Yongmin Yan China	45	5.5k 1.3×	2.9k 1.3×	2.0k 1.4×	1.2k 1.3×	736 0.8×	103	7.8k
Bin Zhang China	43	6.3k 1.5×	3.4k 1.5×	1.6k 1.1×	886 0.9×	1.4k 1.5×	177	9.1k
Koichi Hattori Japan	33	4.9k 1.2×	2.1k 0.9×	1.3k 0.9×	891 0.9×	1.3k 1.3×	64	7.7k
Francisco J. Vizoso Spain	39	2.4k 0.6×	2.1k 0.9×	1.2k 0.8×	1.0k 1.1×	953 1.0×	199	6.5k
Maria Felice Brizzi Italy	45	3.4k 0.8×	1.5k 0.7×	477 0.3×	665 0.7×	1.0k 1.1×	142	5.8k
Mitsuhiko Osaki Japan	44	4.1k 1.0×	1.8k 0.8×	533 0.4×	955 1.0×	466 0.5×	158	6.8k
Tong Chen China	35	3.1k 0.7×	1.4k 0.6×	407 0.3×	519 0.5×	538 0.6×	218	5.2k
Noel M. Caplice United States	43	2.8k 0.7×	666 0.3×	960 0.7×	1.8k 1.9×	705 0.8×	114	6.0k
Robert Flaumenhaft United States	49	2.7k 0.7×	732 0.3×	513 0.4×	775 0.8×	1.1k 1.2×	161	7.7k
Lixin Wei China	55	4.1k 1.0×	2.0k 0.9×	698 0.5×	1.1k 1.1×	1.5k 1.6×	244	9.1k

Countries citing papers authored by Fei Mao

Since Specialization

Citations

This map shows the geographic impact of Fei Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Mao more than expected).

Fields of papers citing papers by Fei Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Mao. The network helps show where Fei Mao may publish in the future.

Co-authorship network of co-authors of Fei Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Mao. A scholar is included among the top collaborators of Fei Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Mao. Fei Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Su, Xuanji He, Fei Mao, & Ying Chu. (2025). Mitochondrial targeting of coenzyme Q10 in inflammatory bowel disease: mechanisms, challenges, and prospects for clinical application. International Immunopharmacology. 166. 115529–115529. 1 indexed citations

Jiang, Dong, Xinfeng Zhang, Lin Luo, et al.. (2025). Cytosine Methylation Changes the Preferred Cis-Regulatory Configuration of Arabidopsis WUSCHEL-Related Homeobox 14. International Journal of Molecular Sciences. 26(2). 763–763. 6 indexed citations

Xiu, Wang, et al.. (2024). The emerging role of the gut microbiota and its application in inflammatory bowel disease. Biomedicine & Pharmacotherapy. 179. 117302–117302. 36 indexed citations

Wu, Xinxin, et al.. (2024). Exosomes derived from microRNA-540-3p overexpressing mesenchymal stem cells promote immune tolerance via the CD74/nuclear factor-kappaB pathway in cardiac allograft. World Journal of Stem Cells. 16(12). 1022–1046. 4 indexed citations

Xu, Xinwei, et al.. (2023). Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis. European journal of medical research. 28(1). 319–319. 26 indexed citations

Ocansey, Dickson Kofi Wiredu, et al.. (2023). Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review). International Journal of Molecular Medicine. 51(6). 44 indexed citations

Yuan, Zhen, Xiaotian Zhang, Hao Chen, et al.. (2023). Sea-ATI unravels novel vocabularies of plant active cistrome. Nucleic Acids Research. 51(21). 11568–11583. 7 indexed citations

Zhao, Rui, Fei Mao, Hui Qian, et al.. (2023). Micro-/Nano-structured Biomaterials for Bone Regeneration: New Progress. Journal of Inorganic Materials. 38(7). 750–750. 2 indexed citations

Wei, Zhiping, Dickson Kofi Wiredu Ocansey, Zhaoyang Zhang, et al.. (2023). Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis. Journal of Nanobiotechnology. 21(1). 188–188. 65 indexed citations

10.

Wang, Jingyan, Bing Pei, Xinwei Xu, et al.. (2022). hucMSC-Derived Exosomes Alleviate the Deterioration of Colitis via the miR-146a/SUMO1 Axis. Molecular Pharmaceutics. 19(2). 484–493. 21 indexed citations

11.

Tang, Xiaohua, et al.. (2022). HucMSC-Ex carrying miR-203a-3p.2 ameliorates colitis through the suppression of caspase11/4-induced macrophage pyroptosis. International Immunopharmacology. 110. 108925–108925. 39 indexed citations

12.

Ocansey, Dickson Kofi Wiredu, Bing Pei, Xinwei Xu, et al.. (2021). Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease. Journal of Translational Medicine. 19(1). 254–254. 12 indexed citations

13.

Mao, Fei, et al.. (2020). Investigation of Leptin G19A polymorphism with bladder cancer risk: A case‐control study. Journal of Clinical Laboratory Analysis. 34(8). e23351–e23351. 5 indexed citations

14.

Yuan, Jintao, Jingyan Wang, Xiu Jun Cai, et al.. (2020). Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease by inhibiting ERK phosphorylation in neutrophils. Inflammopharmacology. 28(2). 603–616. 33 indexed citations

15.

Sun, Yaoxiang, Hui Shi, Siqi Yin, et al.. (2018). Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. ACS Nano. 12(8). 7613–7628. 354 indexed citations breakdown →

16.

Gu, Shuo, et al.. (2018). NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells. Chemico-Biological Interactions. 294. 40–47. 4 indexed citations

17.

Mao, Fei, Jingjing Kang, Xiu Jun Cai, et al.. (2017). Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. Współczesna Onkologia. 2(2). 91–97. 17 indexed citations

18.

Mao, Fei, Yunbing Wu, Xudong Tang, et al.. (2017). Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease through the regulation of 15-LOX-1 in macrophages. Biotechnology Letters. 39(6). 929–938. 29 indexed citations

19.

Pan, Zhaoji, Bin Zhang, Xu Zhang, et al.. (2017). YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression. International Journal of Oncology. 51(4). 1055–1066. 31 indexed citations

20.

Zhang, Bin, Li Shen, Hui Shi, et al.. (2016). Exosomes from Human Umbilical Cord Mesenchymal Stem Cells: Identification, Purification, and Biological Characteristics. Stem Cells International. 2016(1). 1929536–1929536. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact